Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2012 February;60(1) > Minerva Cardioangiologica 2012 February;60(1):85-94

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


eTOC

 

  INTERVENTIONAL CARDIOLOGY


Minerva Cardioangiologica 2012 February;60(1):85-94

language: English

Review of the MitraClip clinical evidence

Maisano F., Taramasso M., Cioni M., Buzzatti N., Denti P., Colombo A., Alfieri O.

Cardiothoracic Department, San Raffaele Hospital, Milan, Italy


PDF  


MitraClip system is the only catheter-based device for percutanoeus mitral valve repair available for clinical use, after receipt of the CE Mark in 2008, while it is currently under review for FDA approval in the US. To date, over 3500 MitraClip implants have been performed worldwide, mainly in high risk surgical patients. The aim of this review is to review all the current evidences of the MitraClip therapy in an aim to define its clinical role in the treatment of mitral regurgitation (MR).

top of page

Publication History

Cite this article as

Corresponding author e-mail

francesco.maisano@hsr.it